Data suggested that the hormonal changes associated with pregnancy and lactation should not discourage breastfeeding after ...
Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment ...
Breastfeeding appears feasible and safe for breast cancer survivors with BRCA1/2 mutations or hormone receptor-positive disease ...
New York, September 15 (IANS): Three new studies on Sunday showed how post-treatment lifestyle choices shape long-term ...
"With this new information, we can debunk the myth that breastfeeding is neither possible nor safe for breast cancer ...
Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...
Breastfeeding is feasible for patients with hormone receptor–positive breast cancer who are undergoing a break of endocrine ...
Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.
“All of a sudden, I had to go through a bunch of appointments with specialists, and I got the news that I had breast cancer.
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Three new studies on Sunday showed how post-treatment lifestyle choices shape long-term outcomes after diagnosis of breast ...